Viewing StudyNCT06462365

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:17 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06462365
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2024-06-06
Brief Title: Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant HSCT
Sponsor: Tr1X Inc
Organization: Tr1X Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Hematologic Malignancy
GvHD
GVHDAcute
GVHD Chronic
Hematopoietic Stem Cell Transplant
Acute Lymphoblastic Leukemia Adult B-Cell
Acute Lymphoblastic Leukemia Adult T-Cell
Acute Myeloid Leukemia in Remission
Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia in Remission
Cancer Remission
Keywords:
Name View
AML View
CMML View
Stem Cell Transplant View
B-ALL View
T-ALL View
Acute GvHD View
Graft versus Host Disease View
Chronic GvHD View
MDS View
Cellular Therapy View
Autoimmune View
T regulatory cells View